The impact of primary Sjögren's syndrome on female sexual function

Rheumatology (United Kingdom)

Volumn 54, Issue 7, 2015, Pages 1286-1293

  Van Nimwegen, Jolien F ^a   Arends, Suzanne ^a   Van Zuiden, Greetje S ^a   Vissink, Arjan ^a   Kroese, Frans G M ^a   Bootsma, Hendrika ^a  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

Author keywords

Aetiology; Female sexual distress scale; Female sexual function index; Healthy volunteers; Sexual distress; Sexual dysfunction; Sj gren's syndrome; Vaginal dryness

Indexed keywords

ADULT; ARTICLE; CLINICAL ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; DEPRESSION; DISEASE ACTIVITY; DISTRESS SYNDROME; EUROPEAN LEAGUE AGAINST RHEUMATISM SJOGREN'S SYNDROME DISEASE ACTIVITY INDEX; FEMALE; FEMALE SEXUAL DISTRESS SCALE; FEMALE SEXUAL DYSFUNCTION; FEMALE SEXUAL FUNCTION INDEX; FUNCTIONAL STATUS ASSESSMENT; GENITAL SYSTEM DISEASE ASSESSMENT; HOSPITAL ANXIETY AND DEPRESSION SCALE; HUMAN; MAUDSLEY MARITAL QUESTIONNAIRE; MULTIDIMENSIONAL FATIGUE INVENTORY; ORGASM; PRIMARY SJOEGREN SYNDROME; PRIORITY JOURNAL; PSYCHOLOGICAL DISTRESS ASSESSMENT; QUALITY OF LIFE ASSESSMENT; RAND 36 ITEM HEALTH SURVEY; SELF REPORT; SEXUAL AROUSAL; SEXUAL BEHAVIOR; SEXUAL FUNCTION; SEXUAL INTERCOURSE; SEXUAL SATISFACTION; SEXUALITY; SJOEGREN SYNDROME; SOCIAL PSYCHOLOGY; VAGINA PAIN; VAGINAL DRYNESS; VAGINAL LUBRICATION; VAGINAL PRURITUS; VAGINITIS;

EID: 84936869436     PISSN: 14620324     EISSN: 14620332     Source Type: Journal    
DOI: 10.1093/rheumatology/keu522     Document Type: Article

References (37)

1. Fox RI. Sjögren's syndrome. Lancet 2005;366:321-31.
2. Cirpan T, Guliyeva A, Onder G et al. Comparison of human papillomavirus testing and cervical cytology with colposcopic examination and biopsy in cervical cancer screening in a cohort of patients with Sjögren's syndrome. Eur J Gynaecol Oncol 2007;28:302-6.
3. Haga HJ, Gjesdal CG, Irgens LM, Ostensen M. Reproduction and gynaecological manifestations in women with primary Sjögren's syndrome: a case-control study. Scand J Rheumatol 2005;34:45-8.
4. Marchesoni D, Mozzanega B, De Sandre P et al. Gynaecological aspects of primary Sjögren's syndrome. Eur J Obstet Gynecol Reprod Biol 1995;63:49-53.
5. Lehrer S, Bogursky E, Yemini M, Kase NG, Birkenfeld A. Gynecologic manifestations of Sjögren's syndrome. Am J Obstet Gynecol 1994;170:835-7.
6. Mulherin DM, Sheeran TP, Kumararatne DS et al. Sjögren's syndrome in women presenting with chronic dyspareunia. Br J Obstet Gynaecol 1997;104:1019-23.
7. Belenguer R, Ramos-Casals M, Brito-Zeron P et al. Influence of clinical and immunological parameters on the health-related quality of life of patients with primary Sjögren's syndrome. Clin Exp Rheumatol 2005;23: 351-6.
8. Skopouli FN, Papanikolaou S, Malamou-Mitsi V, Papanikolaou N, Moutsopoulos HM. Obstetric and gynaecological profile in patients with primary Sjögren's syndrome. Ann Rheum Dis 1994;53:569-73.
9. Stephenson KR, Meston CM. The conditional importance of sex: exploring the association between sexual wellbeing and life satisfaction. J Sex Marital Ther 2015;41: 25-38.
10. de Castro Ferreira C, da Mota LM, Oliveira AC et al. Frequency of sexual dysfunction in women with rheumatic diseases. Rev Bras Reumatol 2013;53:35-46.
11. Anyfanti P, Pyrpasopoulou A, Triantafyllou A et al. The impact of frequently encountered cardiovascular risk factors on sexual dysfunction in rheumatic disorders. Andrology 2013;1:556-62.
12. Ostensen M. New insights into sexual functioning and fertility in rheumatic diseases. Best Pract Res Clin Rheumatol 2004;18:219-32.
13. Tristano AG. The impact of rheumatic diseases on sexual function. Rheumatol Int 2009;29:853-60.
14. Maddali Bongi S, Del Rosso A, Orlandi M, Matucci-Cerinic M. Gynaecological symptoms and sexual disability in women with primary Sjögren's syndrome and sicca syndrome. Clin Exp Rheumatol 2013;31:683-90.
15. Vitali C, Bombardieri S, Jonsson R et al. Classification criteria for Sjögren's syndrome: a revised version of the European criteria proposed by the American-European Consensus Group. Ann Rheum Dis 2002;61:554-8.
16. Rosen R, Brown C, Heiman J et al. The Female Sexual Function Index (FSFI): a multidimensional self-report instrument for the assessment of female sexual function. J Sex Marital Ther 2000;26:191-208.
17. Wiegel M, Meston C, Rosen R. The female sexual function index (FSFI): cross-validation and development of clinical cutoff scores. J Sex Marital Ther 2005;31:1-20.
18. Meyer-Bahlburg HF, Dolezal C. The female sexual function index: a methodological critique and suggestions for improvement. J Sex Marital Ther 2007;33:217-24.
19. Derogatis LR, Rosen R, Leiblum S, Burnett A, Heiman J. The Female Sexual Distress Scale (FSDS): initial validation of a standardized scale for assessment of sexually related personal distress in women. J Sex Marital Ther 2002;28: 317-30.
20. ter Kuile MM, Brauer M, Laan E. The Female Sexual Function Index (FSFI) and the Female Sexual Distress Scale (FSDS): psychometric properties within a Dutch population. J Sex Marital Ther 2006;32:289-304.
21. Seror R, Ravaud P, Bowman SJ et al. EULAR Sjögren's syndrome disease activity index: development of a consensus systemic disease activity index for primary Sjögren's syndrome. Ann Rheum Dis 2010;69:1103-9.
22. Seror R, Ravaud P, Mariette X et al. EULAR Sjögren's Syndrome Patient Reported Index (ESSPRI): development of a consensus patient index for primary Sjögren's syndrome. Ann Rheum Dis 2011;70:968-72.
23. Seror R, Gottenberg JE, Devauchelle-Pensec V et al. European League Against Rheumatism Sjögren's Syndrome Disease Activity Index and European League Against Rheumatism Sjögren's Syndrome Patient-Reported Index: a complete picture of primary Sjögren's syndrome patients. Arthritis Care Res 2013;65:1358-64.
24. Smets EM, Garssen B, Bonke B, De Haes JC. The Multidimensional Fatigue Inventory (MFI) psychometric qualities of an instrument to assess fatigue. J Psychosom Res 1995;39:315-25.
25. Bjelland I, Dahl AA, Haug TT, Neckelmann D. The validity of the Hospital Anxiety and Depression Scale. An updated literature review. J Psychosom Res 2002;52:69-77.
26. Spinhoven P, Ormel J, Sloekers PP et al. A validation study of the Hospital Anxiety and Depression Scale (HADS) in different groups of Dutch subjects. Psychol Med 1997;27:363-70.
27. Arrindell WA, Boelends W, Lambert H. On the psychometric properties of the Maudsley Marital (MMQ): evaluation of self-ratings in distressed and 'normal' volunteer couples based on the Dutch version. Pers Indiv Differ 1983;4:293-306.
28. Van der Zee KI, Sanderman R. Het meten van de algemene gezondheidstoestand met de RAND-36: een handleiding. Groningen, The Netherlands: Rijksuniversiteit Groningen, Noordelijk Centrum voor Gezondheidsvraagstukken, 1993.
29. Schouffoer AA, van der Marel J, Ter Kuile MM et al. Impaired sexual function in women with systemic sclerosis: a cross-sectional study. Arthritis Rheum 2009;61: 1601-8.
30. Tseng JC, Lu LY, Hu JC et al. The impact of systemic lupus erythematosus on women's sexual functioning. J Sex Med 2011;8:3389-97.
31. Fabre LF, Smith LC. The effect of major depression on sexual function in women. J Sex Med 2012;9:231-9.
32. Cho HJ, Yoo JJ, Yun CY et al. The EULAR Sjögren's syndrome patient reported index as an independent determinant of health-related quality of life in primary Sjögren's syndrome patients: in comparison with non-Sjögren's sicca patients. Rheumatology 2013;52: 2208-17.
33. Segal BM, Pogatchnik B, Holker E et al. Primary Sjögren's syndrome: cognitive symptoms, mood, and cognitive performance. Acta Neurol Scand 2012;125: 272-8.
34. Segal B, Thomas W, Rogers T et al. Prevalence, severity, and predictors of fatigue in subjects with primary Sjögren's syndrome. Arthritis Rheum 2008;59:1780-7.
35. Meijer JM, Meiners PM, Vissink A et al. Effectiveness of rituximab treatment in primary Sjögren's syndrome: a randomized, double-blind, placebo-controlled trial. Arthritis Rheum 2010;62:960-8.
36. Meiners PM, Arends S, Brouwer E et al. Responsiveness of disease activity indices ESSPRI and ESSDAI in patients with primary Sjögren's syndrome treated with rituximab. Ann Rheum Dis 2012;71:1297-302.
37. Meiners PM, Vissink A, Kroese FG et al. Abatacept treatment reduces disease activity in early primary Sjögren's syndrome (open-label proof of concept ASAP study). Ann Rheum Dis 2014;73:1393-6.